Skypeptides represent a exceptionally novel class of therapeutics, designed by strategically combining short peptide sequences with unique structural motifs. These brilliant constructs, often mimicking the secondary structures of larger proteins, are showing immense potential for targeting a broad spectrum of diseases. Unlike traditional peptide th

VIP peptide has emerged as a compelling therapeutic target for a spectrum of diseases. This neuropeptide exhibits significant effects on the nervous system, influencing processes such as pain perception, inflammation, and gut function. Research suggests that VIP peptide may hold promise in treating conditions such as autoimmune disorders, brain dis